![]() |
市场调查报告书
商品编码
1828174
2025年全球胸骨闭合系统市场报告Sternal Closure Systems Global Market Report 2025 |
近年来,胸骨闭合系统市场稳定成长,预计2024年将达到23.4亿美元,2025年将达到24.3亿美元,复合年增长率为4.0%。预测期内的增长归因于心血管手术的增加、心血管疾病的流行、对胸骨併发症认识的提高、外科医生与设备製造商之间的合作以及对微创心血管手术的关注。
预计未来几年胸骨闭合系统市场将强劲成长,到2029年将达到30.7亿美元,复合年增长率为6.0%。预测期内的增长可归因于微创手术的快速增长、对以患者为中心的医疗保健的日益重视、新兴市场心臟手术的扩张、对减少术后併发症的重视以及研发合作。预测期内的主要趋势包括器械材料的创新、手术技术的进步、微创方法、胸骨固定技术、无线远端监控、客製化以及针对特定患者的解决方案。
胸骨闭合系统是用于牢固闭合胸骨(保护心臟和肺部的胸部中央骨骼)的医疗设备或方法。这些系统在闭合胸腔时起着至关重要的作用,因为在心血管手术或其他需要进入胸腔的手术中,胸腔可能会打开。
胸骨闭合系统的主要产品类型是闭合装置和骨水泥,用于正中胸骨切开术、半胸骨切开术和双侧胸骨切开术等手术。胸骨闭合装置经过特殊设计,可在癒合过程中稳定胸骨,降低併发症风险并促进更快康復。这些装置用于开胸手术后闭合胸骨。胸骨闭合系统常用的材料包括钛、聚醚醚酮 (PEEK) 和不銹钢。这些系统广泛应用于各种医疗机构,包括医院、诊所、研究机构和其他医疗机构。
2025年,美国关税的大幅上调及其引发的贸易摩擦将对医疗设备产业产生重大影响,尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品的影响。由于医院和诊所抵制价格上涨,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场进入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新研究报告系列的一部分,该系列提供了胸骨闭合系统的市场统计数据,包括全球市场规模、区域份额、竞争对手的市场份额、详细的胸骨闭合系统细分市场、市场趋势和商业机会,以及在胸骨闭合系统行业取得成功所需的其他数据。这份胸骨闭合系统市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的全面观点。
未来五年6.0%的预测成长率,较我们先前对该市场的预测略有下降,下降了0.3%。下降的主要原因是美国与其他国家之间关税的影响。这一影响将直接影响美国,导致钛电镀系统和胸骨丝合金等关键部件的供应链中断,这些部件来自瑞典、比利时和新加坡等主要地区,可能导致心血管手术延误和成本增加。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,这一影响也将更为广泛地显现。
预计胸骨闭合市场的成长将受到慢性病盛行率上升的推动。慢性病的特征是病程持续一年以上,需要持续的医疗护理,通常需要外科手术干预,例如冠状动脉绕道手术术 (CABG) 和瓣膜置换术术。这些手术需要胸骨切开术,因此有效的胸骨闭合至关重要。例如,根据美国美国卫生研究院 (NIH) 的报告,预计到 2050 年,美国50 岁及以上患有至少一种慢性病的人数将从 2020 年的 71,522,000 人增加 99.5% 至 142,660,000 人。此外,预计到 2050 年,患有多种疾病的人数将从 2020 年的 7,834,000 人增加 91.16% 至 14,968,000 人。因此,慢性病盛行率的上升是胸骨闭合器市场的主要驱动力。
心血管疾病的日益普及预计将推动胸骨闭合系统市场的发展。许多心血管疾病都需要手术治疗,而手术又需要打开胸骨。胸骨闭合系统有助于在手术后有效地闭合胸骨。例如,美国心臟学会发布的一项研究预测,2025年至2060年间,中风风险将增加33.8%,使1,500万人死亡。此外,在同一时期,心臟衰竭的风险预计将增加33.4%,使1,300万人死亡;心臟病的风险预计将增加30.7%,使2,900万人死亡;心臟病发作的风险预计将增加1,600万人,即增加16.9%。因此,心血管疾病的日益普及正在推动胸骨闭合系统市场的发展。
预计老年人口的成长将推动胸骨闭合器市场的成长。 65岁及以上的老年人口易发生胸骨併发症,例如胸骨撕脱(手术后胸骨分离)。加强型胸骨闭合系统已被证明对接受心臟直视手术的老年患者有效且安全。根据世界卫生组织 (WHO) 2022年10月的报告,到2030年,全球六分之一的人将年满60岁或以上。预计到2050年,全球60岁以上人口将翻倍,达到21亿人。此外,2020年至2050年间,80岁以上人口将增加4.26亿。因此,不断增长的老年人口是胸骨闭合器市场成长的主要驱动力。
为了提升客户服务,主要企业正在对胸骨闭合器市场的公司进行策略性投资。这些投资使企业能够开发和推出创新的胸骨闭合系统,增强其竞争地位,并推动市场发展。例如,2022年2月,德国特种化学品公司赢创投资了美国新兴企业CircumFix Solutions,该公司开发了一种新型胸骨闭合装置,以促进患者在心臟直视手术后的康復。这款取得专利的整形外科装置由赢创的高性能聚合物製成,可在手术后牢固地闭合和固定胸骨。这项投资符合赢创加强其在美国整形外科市场的影响力并支持植入式医疗设备从金属过渡到高性能聚合物的策略。这款创新的胸骨闭合装置有望改善患者的復原和安全性,这清楚地表明了赢创致力于推进医疗技术和改善患者预后的承诺。
产品创新已成为胸骨闭合系统市场的关键趋势。为了保持竞争力,主要企业正在推出新产品,例如Valkyrie胸骨环状缝线。例如,2023年1月,美国心胸外科产品製造商Able Medical Devices推出了专为心血管手术设计的Valkyrie胸骨环状缝线。此缝合线由不銹钢製成,采用环形金属丝设计,方便开胸手术后胸骨闭合。作为Able Medical改善胸腔外科手术效果策略的一部分,Valkyrie缝合线可提供可靠的胸骨闭合,并在癒合过程中提供稳定性和支撑。
胸骨闭合系统市场的主要公司包括 Zimmer Biomet、强生、B. Braun Melsungen AG、Depuy Synthes、KLS Martin Group、Medtronic PLC、A&E Medical Corporation、Stryker Corporation、Kinamed Incorporated、Acumed LLC、Peters Surgical、Orthofix Medical Inc.、Praen Medical. Medical Appliance Co.Ltd.、GPC Medical、Ulrich GmbH & Co.KG、Biomet Microfixation、Idea SRL、Dispomedica GmbH、Scanlan International Inc.、ELLA-CS, sro、Praesidia SRL、Teleflex Incorporated、Invibio Biomaterial Solutions、Eag-Medical Inc.St.
2024年,胸骨闭合系统市场规模最大的地区是北美洲。根据全球胸骨闭合系统市场报告,预测期内,亚太地区预计将成为成长最快的地区。胸骨闭合系统市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。
胸骨闭合系统市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙。
胸骨闭合系统市场涵盖胸骨闭合手术中使用的导线、钩和油灰的销售。此市场的价值是指“出厂价”,即商品製造商或生产商向其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。
A sternal closure system is a medical device or method employed to securely close the sternum, the central bone in the chest that safeguards the heart and lungs. These systems play a crucial role in closing the chest, which may be opened during heart surgeries or other procedures requiring access to the chest cavity.
The primary product types of sternal closure systems encompass closure devices, bone cement, and are utilized in procedures such as median sternotomy, hemisternotomy, bilateral thoracosternotomy, among others. Sternal closure devices are specifically designed to hold the sternum together during the healing process, reducing the risk of complications and promoting a faster recovery. These devices find application in closing the sternum, or breastbone, following open-heart surgery. Common materials used in sternal closure systems include titanium, polyether ether ketone (PEEK), stainless steel, and others. The system is utilized by various healthcare facilities, including hospitals and clinics, research institutes, and other medical settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The sternal closure system market research report is one of a series of new reports from The Business Research Company that provides sternal closure system market statistics, including sternal closure system industry global market size, regional shares, competitors with a sternal closure system market share, detailed sternal closure system market segments, market trends and opportunities, and any further data you may need to thrive in the sternal closure system industry. This sternal closure system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sternal closure systems market size has grown steadily in recent years. It will grow from $2.34 billion in 2024 to $2.43 billion in 2025 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to rise in cardiovascular surgeries, prevalence of cardiovascular diseases, increasing awareness of sternal complications, collaboration between surgeons and device manufacturers, focus on minimally invasive cardiac procedures.
The sternal closure systems market size is expected to see strong growth in the next few years. It will grow to $3.07 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to rapid growth in minimally invasive surgery, increased focus on patient-centric healthcare, expansion of cardiac surgery in emerging markets, focus on reducing postoperative complication, collaboration in research and development. Major trends in the forecast period include technological innovations in device materials, technological advancements in surgical techniques, minimally invasive approaches, sternum fixation technologies, wireless remote monitoring, customization and patient-specific solutions.
The forecast of 6.0% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for critical components like titanium plating systems and sternal wire alloys, sourced from key regions such as Sweden, Belgium, and Singapore, which could lead to surgical delays and increased costs for cardiac procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated growth in the sternal closure market is expected to be driven by the rising incidence of chronic diseases. Chronic diseases, characterized by lasting for a year or longer and demanding continuous medical care, often require surgical interventions such as coronary artery bypass grafting (CABG) or valve replacement. Given that these surgeries involve sternal incisions, the importance of effective sternal closure becomes crucial. For instance, a report from the National Institutes of Health (NIH) predicts a 99.5% increase in the number of people aged 50 and older with at least one chronic illness in the United States, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity is projected to rise by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. Hence, the growing incidence of chronic diseases is a key driver for the sternal closure market.
A higher prevalence of cardiovascular diseases is expected to propel the sternal closure system market. Many cardiovascular conditions necessitate surgery, during which the sternum bone must be opened. The sternal closure system proves valuable in effectively closing the sternum following such surgeries. For example, research published by the American College of Cardiology indicates a projected 33.8% increase in the risk of stroke to 15 million individuals from 2025 to 2060. Additionally, during the same period, the risk of heart failure is expected to rise by 33.4% to 13 million individuals, heart disease by 30.7% to 29 million individuals, and heart attack by 16.9% to 16 million individuals. Consequently, the heightened prevalence of cardiovascular diseases is a driving force behind the sternal closure system market.
The expected growth in the sternal closure market is anticipated to be fueled by the increasing geriatric population. The geriatric population, comprising individuals aged 65 and older, is more susceptible to sternal complications, such as sternal dehiscence (the separation of the sternum after surgery). The utilization of reinforced sternal closure systems has proven effective and safe in elderly patients undergoing open-heart surgery. According to a report from the World Health Organization (WHO) in October 2022, one in six individuals worldwide will be 60 years or older by 2030. The global population of individuals over 60 is projected to double to 2.1 billion by 2050. Additionally, between 2020 and 2050, there will be an increase of 426 million people aged 80 or older. Consequently, the rising geriatric population is a significant driver for the growth of the sternal closure market.
Major companies are making strategic investments in firms operating in the sternal closure market to enhance customer service. These investments empower companies to develop and introduce innovative sternal closure systems, strengthening their competitive position and propelling market growth. For example, in February 2022, Evonik, a Germany-based specialty chemicals company, invested in CircumFix Solutions, a US-based start-up that developed a new sternal closure device to enhance patient recovery after open-chest surgery. The patented orthopedic device, composed of a high-performance polymer from Evonik, securely closes and holds the sternum together after surgery. This investment aligns with Evonik's strategy to bolster its presence in the U.S. orthopedic market and support the shift from metal to high-performance polymers in implantable medical devices. The innovative sternal closure device is anticipated to improve patient recovery and safety, underscoring Evonik's commitment to advancing medical technology and enhancing patient outcomes.
Product innovations are emerging as a key trend in the sternal closure system market. Leading companies are introducing new products, such as Valkyrie Looped Sternotomy Sutures, to maintain their competitive edge. For example, in January 2023, Able Medical Devices, a US-based manufacturer of cardiothoracic products, launched the Valkyrie Looped Sternotomy Sutures, designed specifically for heart surgeries. Constructed from stainless steel, these sutures feature a looped wire design to facilitate sternum closure after open-heart procedures. As part of Able Medical's strategy to enhance thoracic surgery outcomes, the Valkyrie sutures provide dependable sternum approximation, offering stability and support during the healing process.
Major companies operating in the sternal closure systems market include Zimmer Biomet, Johnson & Johnson, B. Braun Melsungen AG, Depuy Synthes, KLS Martin Group, Medtronic PLC, A&E Medical Corporation, Stryker Corporation, Kinamed Incorporated, Acumed LLC, Peters Surgical, Orthofix Medical Inc., Praesidia SRL, Waston Medical, ABYRX Inc., Jeil Medical Corporation, Jace Medical, Changzhou Waston Medical Appliance Co. Ltd., GPC Medical, Ulrich GmbH & Co. KG, Biomet Microfixation, Idear SRL, Dispomedica GmbH, Scanlan International Inc., ELLA-CS, s.r.o., Praesidia SRL, Teleflex Incorporated, Invibio Biomaterial Solutions, Eagle BioMedical Inc., Z-Medical GmbH & Co. KG
North America was the largest region in the sternal closure system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sternal closure system market report during the forecast period. The regions covered in the sternal closure systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the sternal closure systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The sternal closure system market consists of sales of wires, hooks, and putty that are used for sternal closure procedures. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sternal Closure Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sternal closure systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for sternal closure systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sternal closure systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.